Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Kisspeptin Cost Per Month Budget: Research Peptide Comparison

Kisspeptin-10 3mg (daily 100mcg protocol) $85–$110 $90–$135 21–28 days at 2–8°C GnRH research standard. Higher per-dose cost than generic peptides but irreplaceable for reproductive hormone studies; budget must account for 28-day replacement regardless of rema

This comparison does not assign a generated winner or score.

  • Kisspeptin-10
  • 3mg (daily 100mcg protocol)
  • $85–$110
  • $90–$135
  • 21–28 days at 2–8°C
  • GnRH research standard. Higher per-dose cost than generic peptides but irreplaceable for reproductive hormone studies; budget must account for 28-day replacement regardless of remaining volume
  • GnRH (Gonadorelin)
  • 2.5mg (daily 83mcg protocol)
  • $60–$85
  • $70–$105
  • 14–21 days at 2–8°C
  • Direct GnRH administration bypasses kisspeptin signalling. Lower cost but doesn't model endogenous regulation pathways; shorter stability window increases waste
  • GHRP-6
  • 6mg (daily 200mcg protocol)
  • $45–$65
  • $55–$85
  • 30–45 days at 2–8°C
  • Growth hormone secretagogue with longer stability and lower cost. Suitable for metabolic studies but unrelated mechanism to kisspeptin/GnRH axis
  • Melanotan II
  • 10mg (intermittent dosing)
  • $35–$55
  • $40–$70
  • 60–90 days at 2–8°C
  • Melanocortin receptor agonist with excellent stability and low cost. Not comparable for reproductive research but shows cost floor for research peptides
  • Tesamorelin
  • 2mg (daily 67mcg protocol)
  • $95–$130
  • $105–$155
  • 7–14 days at 2–8°C
  • GHRH analogue with shortest stability window and highest cost-per-dose. Demonstrates that kisspeptin sits mid-range in peptide research budgeting despite niche application
More references

Related material